|
|
Volumn 375, Issue 9723, 2010, Pages 1343-
|
|
The BALANCE trial
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GENERIC DRUG;
LITHIUM;
VALPROIC ACID;
LITHIUM CARBONATE;
TRANQUILIZER;
BIPOLAR I DISORDER;
CLINICAL RESEARCH;
DEVELOPING COUNTRY;
DRUG COST;
DRUG FORMULATION;
HOSPITAL;
HUMAN;
LETTER;
LOWEST INCOME GROUP;
MONOTHERAPY;
PRESCRIPTION;
PRIORITY JOURNAL;
STATISTICAL ANALYSIS;
TREATMENT RESPONSE;
BIPOLAR DISORDER;
DRUG COMBINATION;
ECONOMICS;
NOTE;
ANTIMANIC AGENTS;
BIPOLAR DISORDER;
DRUG THERAPY, COMBINATION;
HUMANS;
LITHIUM CARBONATE;
VALPROIC ACID;
|
|
EID: 77950796939
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(10)60568-5 Document Type: Letter |
|
Times cited : (3)
|
|
References (1)
|
